
0:00
17:03
The haematuria pathway now it is risk-stratified, why the chest scan you were taught to order has largely gone, where NICE and the EAU genuinely disagree on follow-up, what counts as BCG failure and what you can offer when it happens, muscle-invasive disease including the chemotherapy substitution that costs a cure, first-line metastatic treatment, who needs a second resection, and why the upper tract behaves differently.
More episodes from "FRCS in 15"



Don't miss an episode of “FRCS in 15” and subscribe to it in the GetPodcast app.







